TransCure bioServices

Humanized mouse models

TransCure bioServices was founded in 2012, lists 51–200 employees, and has 1 recorded funding round.

Employees
51–200
Founded
2012
Business Model
B2B
Last Round
Venture RoundJun 2019
Rounds
1

Indexed holds 1 funding round for this company. The full record is or through the API.

About

TransCure bioServices is a European preclinical CRO founded in 2012 in Archamps, France. The company develops humanized mouse platforms with functional human immune systems and human hepatocytes to support predictive in vivo pharmacology for immuno-oncology, inflammation, autoimmune, infectious, and liver diseases. More than 300 biotechs, pharmaceutical companies, and academic institutions across 20-plus countries rely on its in vitro and in vivo teams for drug profiling and candidate selection. The company grew from a small HIV-research group to more than 70 full-time employees while remaining fully based in France.

Summary

TransCure bioServices is a Biotech company, founded in 2012. It lists 51–200 employees. Its most recent funding was a Venture Round in Jun 2019.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJun 2019

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TransCure bioServices on Indexed.vc
<a href="https://indexed.vc/companies/transcure-bioservices"><img src="https://indexed.vc/api/badge/company/transcure-bioservices" alt="TransCure bioServices on Indexed.vc" width="260" height="76" /></a>